导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.38% | 1544/4773 |
| 近一周 | -0.76% | 1839/5467 |
| 近一月 | -6.07% | 2845/5421 |
| 近一季 | -10.11% | 3240/5238 |
| 近半年 | -3.21% | 2638/4931 |
| 近一年 | 6.38% | 1409/4400 |
| 近两年 | 69.93% | 1013/2954 |
| 近三年 | 35.76% | 865/2253 |
| 成立以来 | 84.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.75% 1190/4961 |
18.19% 1408/5312 |
- - |
- - |
| 2025 | 30.27% 1338/4813 |
2.08% 1470/3635 |
1.89% 2042/4076 |
24.24% 1486/4524 |
0.82% 1749/4813 |
| 2024 | 5.78% 1811/3463 |
-2.64% 1396/2808 |
-5.30% 1686/3014 |
15.56% 1683/3129 |
-0.72% 1508/3463 |
| 2023 | -5.88% 789/2656 |
7.58% 551/2280 |
-3.98% 989/2385 |
-4.61% 1177/2515 |
-4.48% 1055/2655 |
| 2022 | -17.94% 643/2207 |
-13.30% 728/1919 |
3.07% 1221/2016 |
-10.47% 409/2113 |
2.56% 899/2208 |
| 2021 | 16.32% 272/1822 |
-1.48% 497/1255 |
9.32% 565/1330 |
4.66% 328/1466 |
3.19% 463/1822 |
| 2020 | 20.89% 702/1250 |
-4.79% 382/1028 |
16.55% 430/1067 |
6.37% 848/1164 |
2.42% 988/1184 |
| 2019 | 25.31% 604/1092 |
30.69% 235/754 |
-9.97% 707/804 |
0.39% 519/850 |
6.09% 657/918 |
| 2018 | - - |
- - |
- - |
- - |
-11.83% 361/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 嘉实中证500ETF联接C VS. 长安沪深300非周期A(740101) |